Skip to main content
Top
Published in: Head and Neck Pathology 4/2018

01-12-2018 | Original Paper

Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America

Authors: Natália Rocha Bedran, Román Carlos, Bruno Augusto Benevenuto de Andrade, Ana Paula Silva Bueno, Mário José Romañach, Cristiane Bedran Milito

Published in: Head and Neck Pathology | Issue 4/2018

Login to get access

Abstract

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic proliferation with variable clinical behavior caused by the accumulation of CD1a+/CD207+ histiocytes, associated with a variable number of eosinophils, lymphocytes, plasma cells and multinucleated giant cells, most commonly observed in male children. LCH is uncommon in the head and neck region, occurring as ulcerated and reddened plaques or nodules that cause destruction of adjacent soft tissues and bone. The exact etiology of LCH is still unknown and controversial, with possible etiologic role of viruses, including Epstein–Barr virus (EBV). The aim of this study was to describe the clinicopathologic and immunohistochemical features of patients with LCH of the head and neck region. Clinical data from 19 patients with LCH were obtained from the archives of the Federal University of Rio de Janeiro and the Clinical Head and Neck Center of Guatemala. All cases were submitted to morphological, immunohistochemical analysis with CD1a, CD207, CD3, CD20, CD68, S-100 and Ki-67 and in situ hybridization for EBV. Ten cases were female and 9 male, with mean age of 11.5 years. Fourteen cases were located in the oral cavity, three cases in lymph nodes, and two cases in the scalp. In regard to the oral lesions, 13 cases were intra-osseous with six cases in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla while one case was located exclusively in the gingiva. The inflammatory pattern showed variation in the number of plasma cells, eosinophils and lymphocytes, while tumor cells were positive for CD1a, S-100 and CD68 in all cases, and positive for CD207 in 18 cases. In situ hybridization for EBV were negative in all cases.
Literature
1.
go back to reference Pileri SA, Feldman AL, Cheuk W, Slater L. Langerhans cell histiocytosis. In: El-Nagar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017. pp. 130–1. Pileri SA, Feldman AL, Cheuk W, Slater L. Langerhans cell histiocytosis. In: El-Nagar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017. pp. 130–1.
2.
go back to reference Hicks J, Flaitz. Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:S42–66.CrossRef Hicks J, Flaitz. Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:S42–66.CrossRef
3.
go back to reference Madrigal-Martínez-Pereda C, Guerrero-Rodríguez V, Guisado-Moya B, Meniz-García C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8. Madrigal-Martínez-Pereda C, Guerrero-Rodríguez V, Guisado-Moya B, Meniz-García C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8.
4.
go back to reference Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015;169:3–13.CrossRef Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015;169:3–13.CrossRef
5.
go back to reference Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28:9–14.CrossRef Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28:9–14.CrossRef
6.
go back to reference David R, Oria RA, Kumar R, Singleton EB, Lindell MM, Shirkhoda A, Madewell JE. Radiologic features of eosinophilic granuloma of bone. MR Am J Roentgenol. 1989;153:1021.CrossRef David R, Oria RA, Kumar R, Singleton EB, Lindell MM, Shirkhoda A, Madewell JE. Radiologic features of eosinophilic granuloma of bone. MR Am J Roentgenol. 1989;153:1021.CrossRef
7.
go back to reference Hernández-Juyol M, Boj-Quesada JR, Gallego Melcon S. Oral manifestations of Langerhans cell histiocytosis. Case study of a two year-old boy. Med Oral. 2003;8:19–25. Hernández-Juyol M, Boj-Quesada JR, Gallego Melcon S. Oral manifestations of Langerhans cell histiocytosis. Case study of a two year-old boy. Med Oral. 2003;8:19–25.
8.
go back to reference Mínguez I, Mínguez JM, Bonet J, Peñarrocha M, Sanchis JM. Oral manifestations of chronic disseminated histiocytosis. A report of 10 cases. Med Oral. 2004;9:149–54. Mínguez I, Mínguez JM, Bonet J, Peñarrocha M, Sanchis JM. Oral manifestations of chronic disseminated histiocytosis. A report of 10 cases. Med Oral. 2004;9:149–54.
9.
go back to reference Lewoczko KB, Rohman GT, LeSueur JR, Stocks RM, Thompson JW. Head and neck manifestations of langerhan’s cell histiocytosis in children: a 46-year experience. Int J Pediatr Otorhinolaryngol. 2014;78:1874–6.CrossRef Lewoczko KB, Rohman GT, LeSueur JR, Stocks RM, Thompson JW. Head and neck manifestations of langerhan’s cell histiocytosis in children: a 46-year experience. Int J Pediatr Otorhinolaryngol. 2014;78:1874–6.CrossRef
10.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumors of hematopoietic and lymphoid tissues. 2017; p. 359. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumors of hematopoietic and lymphoid tissues. 2017; p. 359.
11.
go back to reference Querings K, Starz H, Balda BR. Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 2006;86:39–43. Querings K, Starz H, Balda BR. Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 2006;86:39–43.
12.
go back to reference Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, et al. Identical twin brothers concordant for Langerhans’ cell histiocytosis and discordant for Epstein–Barr virus-associated hemophagocytic syndrome. Eur J Pediatr. 2004;163:536–9. Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, et al. Identical twin brothers concordant for Langerhans’ cell histiocytosis and discordant for Epstein–Barr virus-associated hemophagocytic syndrome. Eur J Pediatr. 2004;163:536–9.
13.
go back to reference Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K, Takemura T. Development of Langerhans cell histiocytosis associated with chronic active Epstein–Barr virus infection. Pediatr Blood Cancer. 2008;50:924–7.CrossRef Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K, Takemura T. Development of Langerhans cell histiocytosis associated with chronic active Epstein–Barr virus infection. Pediatr Blood Cancer. 2008;50:924–7.CrossRef
14.
go back to reference Ashraf MJ, Makarempour A, Monabati A, Azarpira N, Khademi B, Hakimzadeh A. Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience. Iran Red Crescent Med J. 2012;14:764–70.CrossRef Ashraf MJ, Makarempour A, Monabati A, Azarpira N, Khademi B, Hakimzadeh A. Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience. Iran Red Crescent Med J. 2012;14:764–70.CrossRef
15.
go back to reference Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K, et al. Expression of Epstein–Barr virus in Langerhans’ cell histiocytosis. Hum Pathol. 2004;35:862–8.CrossRef Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K, et al. Expression of Epstein–Barr virus in Langerhans’ cell histiocytosis. Hum Pathol. 2004;35:862–8.CrossRef
16.
go back to reference Purtilo DT. Epstein–Barr-virus-induced oncogenesis in immunedeficient individuals. Lancet. 1980;1:300–3.CrossRef Purtilo DT. Epstein–Barr-virus-induced oncogenesis in immunedeficient individuals. Lancet. 1980;1:300–3.CrossRef
17.
go back to reference Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.CrossRef Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.CrossRef
18.
go back to reference Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P. Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS ONE. 2008;3:e3262.CrossRef Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P. Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS ONE. 2008;3:e3262.CrossRef
19.
go back to reference McClain K, Jin H, Gresik V, Favara B. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol. 1994;47:16–20.CrossRef McClain K, Jin H, Gresik V, Favara B. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol. 1994;47:16–20.CrossRef
20.
go back to reference Schenka AA, De Angelo Andrade LA, Amstalden EM, Cintra ML, Vassallo J, Cardinalli IA, et al. Langerhans cell histiocytosis and its relationship with Epstein–Barr virus. Hum Pathol. 2006;37:1508–9.CrossRef Schenka AA, De Angelo Andrade LA, Amstalden EM, Cintra ML, Vassallo J, Cardinalli IA, et al. Langerhans cell histiocytosis and its relationship with Epstein–Barr virus. Hum Pathol. 2006;37:1508–9.CrossRef
21.
go back to reference Brousset P. Epstein–Barr virus and Langerhans cell histiocytosis. Hum Pathol. 2004;35:1573–4.CrossRef Brousset P. Epstein–Barr virus and Langerhans cell histiocytosis. Hum Pathol. 2004;35:1573–4.CrossRef
22.
go back to reference Panis V, Nikitakis N, Deskalopoulos A, Maragkou T, Tsiklakis K, Skavouvou A. Langerhans cell histiocytosis mimicking aggressive periodontitis: challenges in diagnosis and management. Quintessence Int. 2016;47:731–8. Panis V, Nikitakis N, Deskalopoulos A, Maragkou T, Tsiklakis K, Skavouvou A. Langerhans cell histiocytosis mimicking aggressive periodontitis: challenges in diagnosis and management. Quintessence Int. 2016;47:731–8.
23.
go back to reference Facciolo MT, Riva F, Gallenzi P, Patini R, Gaglioti D. A rare case of oral multisystem Langerhans cell histiocytosis. J Clin Exp Dent. 2017;9:e820–4. Facciolo MT, Riva F, Gallenzi P, Patini R, Gaglioti D. A rare case of oral multisystem Langerhans cell histiocytosis. J Clin Exp Dent. 2017;9:e820–4.
24.
go back to reference Guimarães LF, Dias PFBPD., Janini ME, Souza IPR. Langerhans cell histiocytosis: impact on the permanent dentition after an 8-year follow-up. J Dent Child. 2008;75:64–8. Guimarães LF, Dias PFBPD., Janini ME, Souza IPR. Langerhans cell histiocytosis: impact on the permanent dentition after an 8-year follow-up. J Dent Child. 2008;75:64–8.
25.
go back to reference Buchmann L, Emami A, Wei JL. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngology 2006;135:312–7.CrossRef Buchmann L, Emami A, Wei JL. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngology 2006;135:312–7.CrossRef
26.
go back to reference Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39:687–94.CrossRef Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39:687–94.CrossRef
27.
go back to reference Murray M, Dean J, Slater L. Multifocal oral langerhans cell histiocytosis. J Oral Maxillofac Surg. 2011;69:2585–91.CrossRef Murray M, Dean J, Slater L. Multifocal oral langerhans cell histiocytosis. J Oral Maxillofac Surg. 2011;69:2585–91.CrossRef
28.
go back to reference Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol. 1992;74:230–6.CrossRef Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol. 1992;74:230–6.CrossRef
29.
go back to reference Nicollas R, Rome A, Belaïch H, Roman S, Volk M, Gentet JC, Michel G, Triglia JM. Head and neck manifestation and prognosis of Langerhans’ cell histiocytosis in children. Int J Pediatr Otorhinolaryngol. 2010;74:669–73.CrossRef Nicollas R, Rome A, Belaïch H, Roman S, Volk M, Gentet JC, Michel G, Triglia JM. Head and neck manifestation and prognosis of Langerhans’ cell histiocytosis in children. Int J Pediatr Otorhinolaryngol. 2010;74:669–73.CrossRef
30.
go back to reference Saliba I, Sidani K, El Fata F, Arcand P, Quintal MC, Abela A. Langerhans’ cell histiocytosis of the temporal bone in children. Int J Pediatr Otorhinolaryngol. 2008;72:775–86.CrossRef Saliba I, Sidani K, El Fata F, Arcand P, Quintal MC, Abela A. Langerhans’ cell histiocytosis of the temporal bone in children. Int J Pediatr Otorhinolaryngol. 2008;72:775–86.CrossRef
31.
go back to reference Yashoda-Devi B, Rakesh N, Agarwal M. Langerhans cell histiocytosis with oral manifestations: a rare and unusual case report. J Clin Exp Dent. 2012;4:e252–5.CrossRef Yashoda-Devi B, Rakesh N, Agarwal M. Langerhans cell histiocytosis with oral manifestations: a rare and unusual case report. J Clin Exp Dent. 2012;4:e252–5.CrossRef
32.
go back to reference Pacino GA, Serrat A, Redondo LM, Verrier A. Langerhans cell histiocytosis: clinical diagnostic features and current concepts. Med Oral. 1999;4:607–18. Pacino GA, Serrat A, Redondo LM, Verrier A. Langerhans cell histiocytosis: clinical diagnostic features and current concepts. Med Oral. 1999;4:607–18.
33.
go back to reference Duncan WK, Post AC, McCoy BP. Eosinophilic granuloma. Oral Surg Oral Med Oral Pathol. 1988;65:736–41.CrossRef Duncan WK, Post AC, McCoy BP. Eosinophilic granuloma. Oral Surg Oral Med Oral Pathol. 1988;65:736–41.CrossRef
34.
go back to reference Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28(1):9–14.CrossRef Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28(1):9–14.CrossRef
35.
go back to reference Stålemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter J. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76e81.CrossRef Stålemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter J. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76e81.CrossRef
36.
go back to reference Hashimoto K, Pritzker MS. Electron microscopic study of reticulohistiocytoma: an unusual case of congenital, self-healing reticulohistiocytosis. Arch Dermatol. 1973;107:263–70.CrossRef Hashimoto K, Pritzker MS. Electron microscopic study of reticulohistiocytoma: an unusual case of congenital, self-healing reticulohistiocytosis. Arch Dermatol. 1973;107:263–70.CrossRef
37.
go back to reference Longaker MA, Frieden IJ, LeBoit PE, Sherertz EF. Congenital ‘‘self-healing’’ Langerhans cell histiocytosis: the need for long-term follow-up. J Am Acad Dermatol. 1994;31:910–6.CrossRef Longaker MA, Frieden IJ, LeBoit PE, Sherertz EF. Congenital ‘‘self-healing’’ Langerhans cell histiocytosis: the need for long-term follow-up. J Am Acad Dermatol. 1994;31:910–6.CrossRef
38.
go back to reference Larralde M, Rositto A, Giardelli M, Gatti CF, Munoz AS. Congenital self-healing histiocytosis (Hashimoto-Pritzker). Int J Dermatol. 1999;38:693–6.CrossRef Larralde M, Rositto A, Giardelli M, Gatti CF, Munoz AS. Congenital self-healing histiocytosis (Hashimoto-Pritzker). Int J Dermatol. 1999;38:693–6.CrossRef
39.
go back to reference Jang KA, Ahn SJ, Choi JH, Sung KJ, Moon KC, Koh JK. Histiocytic disorders with pontaneous regression in infancy. Pediatr Dermatol. 2000;17:364–8.CrossRef Jang KA, Ahn SJ, Choi JH, Sung KJ, Moon KC, Koh JK. Histiocytic disorders with pontaneous regression in infancy. Pediatr Dermatol. 2000;17:364–8.CrossRef
40.
go back to reference Geissmann F, Emile JF, Andry R, Thomas C, Fraitag S, De Prost Y, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans cell histiocytosis and poor outcome. J Pathol. 1997;181:301–4.CrossRef Geissmann F, Emile JF, Andry R, Thomas C, Fraitag S, De Prost Y, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans cell histiocytosis and poor outcome. J Pathol. 1997;181:301–4.CrossRef
41.
go back to reference Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med. 2001;155:778–83.CrossRef Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med. 2001;155:778–83.CrossRef
42.
go back to reference Merglová V, Hrusák D, Boudová L, Mukensnabl P, Valentová E, Hosticka L. Langerhans cell histiocytosis in childhood—review, symptoms in the oral cavity, differential diagnosis and report of two cases. J Craniomaxillofac Surg. 2014;42:93–100.CrossRef Merglová V, Hrusák D, Boudová L, Mukensnabl P, Valentová E, Hosticka L. Langerhans cell histiocytosis in childhood—review, symptoms in the oral cavity, differential diagnosis and report of two cases. J Craniomaxillofac Surg. 2014;42:93–100.CrossRef
43.
go back to reference Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175–84.CrossRef Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175–84.CrossRef
44.
go back to reference Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–81.CrossRef Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–81.CrossRef
45.
go back to reference Ducassou S, Seyrig F, Thomas C, Lambilliotte A, Marec-Berard P, Berger C, et al. Thymus and mediastinal node involvement in childhood Langerhans ceel histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer. 2013;60:1759e65. Ducassou S, Seyrig F, Thomas C, Lambilliotte A, Marec-Berard P, Berger C, et al. Thymus and mediastinal node involvement in childhood Langerhans ceel histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer. 2013;60:1759e65.
46.
go back to reference Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans’ cell histiocytosis (histiocytosis): immunophenotype and growth fraction. Hum Pathol. 1993;24:840–5.CrossRef Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans’ cell histiocytosis (histiocytosis): immunophenotype and growth fraction. Hum Pathol. 1993;24:840–5.CrossRef
47.
go back to reference Bank MI, Rengtved P, Carstensen H, Petersen BL. Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 2003;111:300–8.CrossRef Bank MI, Rengtved P, Carstensen H, Petersen BL. Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 2003;111:300–8.CrossRef
48.
go back to reference Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615–9.CrossRef Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615–9.CrossRef
49.
go back to reference Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, Berghoff AS, Habel A, Schneider M, Kulozik A, Anagnostopoulos I, Mullauer L, Mechtersheimer G, von Deimling A. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012;120:e28–34.CrossRef Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, Berghoff AS, Habel A, Schneider M, Kulozik A, Anagnostopoulos I, Mullauer L, Mechtersheimer G, von Deimling A. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012;120:e28–34.CrossRef
50.
go back to reference Varga E, Korom I, Polyánka H, Szabó K, Széll M, Baltás E, Bata-Csörgő Z, Kemény L, Oláh J. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol. 2015;29:1205–11.CrossRef Varga E, Korom I, Polyánka H, Szabó K, Széll M, Baltás E, Bata-Csörgő Z, Kemény L, Oláh J. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol. 2015;29:1205–11.CrossRef
51.
go back to reference Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995;76(12):2471–84.CrossRef Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995;76(12):2471–84.CrossRef
52.
go back to reference Monsereenusorn C, Rodriguez-Galindo C. Clinical characteristics and treatment of langerhans cell histiocytosis. Hematol Oncol Clin N Am. 2015;29:853–73.CrossRef Monsereenusorn C, Rodriguez-Galindo C. Clinical characteristics and treatment of langerhans cell histiocytosis. Hematol Oncol Clin N Am. 2015;29:853–73.CrossRef
Metadata
Title
Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America
Authors
Natália Rocha Bedran
Román Carlos
Bruno Augusto Benevenuto de Andrade
Ana Paula Silva Bueno
Mário José Romañach
Cristiane Bedran Milito
Publication date
01-12-2018
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 4/2018
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0867-1

Other articles of this Issue 4/2018

Head and Neck Pathology 4/2018 Go to the issue

Sine qua non Radiology-Pathology

Juvenile Trabecular Ossifying Fibroma